Parkinson’s disease

Impulse-control disorders common in Parkinson’s patients taking dopamine agonists

Researchers find that after five years of follow-up, more than half of people taking dopamine agonists for management of Parkinson’s disease developed impulse-control disorders.

Use of dopamine agonists (DAs) in people with Parkinson’s disease is strongly associated with the development of impulse-control disorders (ICDs), according to the results of a study published in Neurology (20 June 2018)[1].

The research included 411 patients who had the disease for less than five years, 86.6% of whom had taken at least one DA since disease onset.

At five years’ follow-up, 51.5% of those exposed to DAs had experienced an ICD, such as pathological gambling or compulsive shopping, eating or sexual behaviours, compared with a rate of 12.4% in those never exposed to DAs. The researchers also found a significant dose-response relationship between DA use and ICDs, and that ICDs resolved after DA discontinuation. In contrast, there was no relationship between other drugs for Parkinson’s disease and ICDs.

“Given the high cumulative incidence of ICDs in patients with PD, these adverse effects should be carefully monitored in patients ever treated with DAs,” the researchers concluded. Tools to screen patients at high-risk of developing ICDs would be beneficial, they added.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205298

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Disease Management

    Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.

  • Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

  • Conducting Your Pharmacy Practice Research Project

    A systematic guide to the stages of the research process, from planning of the project through to dissemination of the findings.

  • Minor Illness or Major Disease

    This established textbook helps you differentiate between minor illnesses which can be safely managed in the pharmacy, and major diseases.

  • Biological Therapeutics

    An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.


Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete

Supplementary images

  • Old man walking with cane

Jobs you might like

  • Leeds, West Yorkshire

  • Corsham, Wiltshire

  • Crowborough, East Sussex

  • London (Greater)

  • Doha

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.